









市場
/
株式
/
nasdaq-txg
/

10X Genomics Inc

TXG

18.340USD

+1.880+11.42%

終値 11/21, 16:00（ET）15分遅れの株価

2.32B時価総額

損失額直近12ヶ月PER



10X Genomics Inc

18.340

+1.880+11.42%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 10X Genomics Inc 企業名

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

10X Genomics Incの企業情報



企業コードTXG

会社名10X Genomics Inc

上場日Sep 12, 2019

最高経営責任者「CEO」Mr. Serge Wilson Saxonov, Ph.D.

従業員数1306

証券種類Ordinary Share

決算期末Sep 12

本社所在地6230 Stoneridge Mall Road

都市PLEASANTON

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号94588

電話番号19254017300

ウェブサイトhttps://www.10xgenomics.com/

企業コードTXG

上場日Sep 12, 2019

最高経営責任者「CEO」Mr. Serge Wilson Saxonov, Ph.D.

10X Genomics Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.06M

-0.09%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+4.34%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+29.09%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+34.83%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

44.69K

-14.35%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+115.82%

Dr. Shehnaaz Suliman, M.D.

Independent Director

28.62K

+115.82%

Mr. Adam S. Taich

Chief Financial Officer

Mr. Alan V. Mateo

Independent Director

Dr. Sarah A. Teichmann

Independent Director

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.06M

-0.09%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+4.34%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+29.09%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+34.83%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

44.69K

-14.35%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+115.82%

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Consumables

122.19M

70.66%

Products and services revenue

27.75M

16.05%

Instruments

14.50M

8.38%

Services

8.47M

4.90%

地域別USD

会社名

収益

比率

United States

103.49M

59.85%

Europe, the Middle East and Africa

34.73M

20.09%

China

23.17M

13.40%

Asia Pacific

8.85M

5.12%

Americas

2.67M

1.54%

事業別

地域別

事業別USD

会社名

収益

比率

Consumables

122.19M

70.66%

Products and services revenue

27.75M

16.05%

Instruments

14.50M

8.38%

Services

8.47M

4.90%

株主

更新時刻: Wed, Nov 19

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

11.38%

ARK Investment Management LLC

10.21%

BlackRock Institutional Trust Company, N.A.

6.68%

Fidelity Management & Research Company LLC

6.19%

Millennium Management LLC

4.67%

他の

60.88%

株主統計

比率

The Vanguard Group, Inc.

11.38%

ARK Investment Management LLC

10.21%

BlackRock Institutional Trust Company, N.A.

6.68%

Fidelity Management & Research Company LLC

6.19%

Millennium Management LLC

4.67%

他の

60.88%

種類

株主統計

比率

Investment Advisor

52.15%

Investment Advisor/Hedge Fund

27.16%

Hedge Fund

14.44%

Research Firm

6.24%

Bank and Trust

5.01%

Venture Capital

1.88%

Individual Investor

1.82%

Family Office

0.84%

Pension Fund

0.54%

機関投資家保有株



更新時刻: Wed, Oct 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q3

675

117.21M

102.45%

-24.61M

2025Q2

669

120.42M

108.39%

-15.20M

2025Q1

687

115.67M

104.27%

-8.84M

2024Q4

689

107.08M

98.92%

-12.41M

2024Q3

682

106.90M

100.39%

-9.08M

2024Q2

691

105.36M

99.70%

-5.09M

2024Q1

762

106.36M

101.17%

-3.12M

2023Q4

817

100.80M

96.01%

-9.73M

2023Q3

835

96.86M

93.80%

-12.55M

2023Q2

857

94.98M

96.77%

-15.37M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

12.42M

10.85%

+1.32M

+11.92%

Jun 30, 2025

ARK Investment Management LLC

13.89M

12.14%

+1.05M

+8.15%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

7.58M

6.63%

+2.17M

+40.18%

Jun 30, 2025

Fidelity Management & Research Company LLC

7.64M

6.68%

-930.78K

-10.85%

Jun 30, 2025

Millennium Management LLC

2.88M

2.52%

-2.65M

-47.89%

Jun 30, 2025

Sumitomo Mitsui Trust Bank, Limited

6.02M

5.26%

+654.60K

+12.20%

Jun 30, 2025

Wellington Management Company, LLP

1.89M

1.65%

+1.89M

Jun 30, 2025

Quantinno Capital Management LP

2.23M

1.95%

+1.51M

+207.23%

Jun 30, 2025

BofA Global Research (US)

2.91M

2.54%

+350.99K

+13.74%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

よくある質問

10X Genomics Incの上位5名の株主は誰ですか？



10X Genomics Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は12.42M株を保有しており、これは全体の10.85%に相当します。
ARK Investment Management LLCは13.89M株を保有しており、これは全体の12.14%に相当します。
BlackRock Institutional Trust Company, N.A.は7.58M株を保有しており、これは全体の6.63%に相当します。
Fidelity Management & Research Company LLCは7.64M株を保有しており、これは全体の6.68%に相当します。
Millennium Management LLCは2.88M株を保有しており、これは全体の2.52%に相当します。